FSL-1 induces MMP-9 production through TLR-2 and NF-κB /AP-1 signaling pathways in monocytic THP-1 cells

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 929-942

  Ahmad, Rasheed ^a   Shihab, Puthiyaveetil Kochumon ^a   Jasem, Sara ^a   Behbehani, Kazem ^a  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

ERK; MMP 9; MyD88; p38; TLR 2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FIBROBLAST STIMULATING LIPOPEPTIDE 1; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPEPTIDE; MESSENGER RNA; NEUTRALIZING ANTIBODY; RESVERATROL; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP 1; TRIPTOLIDE; UNCLASSIFIED DRUG; DIACYLGLYCEROL; FSL-1 LIPOPROTEIN, SYNTHETIC; OLIGOPEPTIDE; TLR2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; METABOLISM;

BLOTTING, WESTERN; CELL LINE; DIGLYCERIDES; HUMANS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; OLIGOPEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP-1;

EID: 84927157786     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366310     Document Type: Article

References (62)

1. Murphy G: Matrix metalloproteinases and their inhibitors. Acta Orthop Scand Suppl 1995;266:55-60.
2. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003;92:827-839.
3. Chen Y, Wei X, Guo C, Jin H, Han Z, Han Y, Qiao T, Wu K, Fan D: Runx3 suppresses gastric cancer metastasis through inactivation of mmp9 by upregulation of timp-1. Int J Cancer 2011;129:1586-1598.
4. Tian TV, Tomavo N, Huot L, Flourens A, Bonnelye E, Flajollet S, Hot D, Leroy X, de Launoit Y, Duterque-Coquillaud M: Identification of novel tmprss2:Erg mechanisms in prostate cancer metastasis: Involvement of mmp9 and plxna2. Oncogene 2014;33:2204-2214.
5. Castano R, Miedinger D, Maghni K, Ghezzo H, Trudeau C, Castellanos L, Wattiez M, Vandenplas O, Malo JL: Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge. Int Arch Allergy Immunol 2013;160:161-164.
6. Devereux G, Steele S, Jagelman T, Fielding S, Muirhead R, Brady J, Grierson C, Brooker R, Winter J, Fardon T, McCormick J, Huang JT, Miller D: An observational study of matrix metalloproteinase (mmp)-9 in cystic fibrosis. J Cyst Fibros 2014
7. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
8. Gong Y, Hart E, Shchurin A, Hoover-Plow J: Inflammatory macrophage migration requires mmp-9 activation by plasminogen in mice. J Clin Invest 2008;118:3012-3024.
9. Andrade VL, Petruceli E, Belo VA, Andrade-Fernandes CM, Caetano Russi CV, Bosco AA, Tanus-Santos JE, Sandrim VC: Evaluation of plasmatic mmp-8, mmp-9, timp-1 and mpo levels in obese and lean women. Clin Biochem 2012;45:412-415.
10. Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G, Kerkau T, Frantz S: Activation of cd4+ t lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012;125:1652-1663.
11. Wong Y, Sethu C, Louafi F, Hossain P: Lipopolysaccharide regulation of toll-like receptor-4 and matrix metalloprotease-9 in human primary corneal fibroblasts. Invest Ophthalmol Vis Sci 2011;52:2796-2803.
12. Kariko K, Weissman D, Welsh FA: Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 2004;24:1288-1304.
13. Wang JH, Kwon HJ, Jang YJ: Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy 2010;24:422-427.
14. Maretti-Mira AC, de Pinho Rodrigues KM, de Oliveira-Neto MP, Pirmez C, Craft N: Mmp-9 activity is induced by leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop 2011;119:160-164.
15. Vanlaere I, Libert C: Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009;22:224-239, Table of Contents.
16. Wang YY, Myhre AE, Pettersen SJ, Dahle MK, Foster SJ, Thiemermann C, Bjornland K, Aasen AO, Wang JE: Peptidoglycan of staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils. Shock 2005;24:214-218.
17. Lu Y, Wahl LM: Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/akt/ikkalpha/nf-kappab pathway. J Leukoc Biol 2005;78:259-265.
18. Shibata K, Hasebe A, Into T, Yamada M, Watanabe T: The n-terminal lipopeptide of a 44-kda membranebound lipoprotein of mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J Immunol 2000;165:6538-6544.
19. Okusawa T, Fujita M, Nakamura J, Into T, Yasuda M, Yoshimura A, Hara Y, Hasebe A, Golenbock DT, Morita M, Kuroki Y, Ogawa T, Shibata K: Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun 2004;72:1657-1665.
20. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 2001;25:402-408.
21. Rose WA, 2nd, McGowin CL, Pyles RB: Fsl-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental hsv-2 infection. Virol J 2009;6:195.
22. Sato H, Seiki M: Regulatory mechanism of 92 kda type iv collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993;8:395-405.
23. Rhee JW, Lee KW, Kim D, Lee Y, Jeon OH, Kwon HJ, Kim DS: Nf-kappab-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line raw 264.7. J Biochem Mol Biol 2007;40:88-94.
24. Shamsul HM, Hasebe A, Iyori M, Ohtani M, Kiura K, Zhang D, Totsuka Y, Shibata K: The toll-like receptor 2 (tlr2) ligand fsl-1 is internalized via the clathrin-dependent endocytic pathway triggered by cd14 and cd36 but not by tlr2. Immunology 2010;130:262-272.
25. Triantafilou M, Manukyan M, Mackie A, Morath S, Hartung T, Heine H, Triantafilou K: Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the golgi are lipid raft-dependent. J Biol Chem 2004;279:40882-40889.
26. Brandt KJ, Fickentscher C, Kruithof EK, de Moerloose P: Tlr2 ligands induce nf-kappab activation from endosomal compartments of human monocytes. PLoS One 2013;8:e80743.
27. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
28. Bond M, Fabunmi RP, Baker AH, Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor nf-kappa b. FEBS Lett 1998;435:29-34.
29. Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ: Transcriptional activation of the matrix metalloproteinase-9 gene in an h-ras and v-myc transformed rat embryo cell line. Oncogene 1997;14:1995-1998.
30. Maeda A, Sobel RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55:300-309.
31. Mignatti P, Rifkin DB: Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996;49:117-137.
32. Aliprantis AO, Weiss DS, Radolf JD, Zychlinsky A: Release of toll-like receptor-2-activating bacterial lipoproteins in shigella flexneri culture supernatants. Infect Immun 2001;69:6248-6255.
33. Medzhitov R, Janeway CA, Jr.: Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997;91:295-298.
34. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-17409.
35. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
36. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of tlr2 and tlr4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-451.
37. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: Recognition of grampositive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J Immunol 1999;163:1-5.
38. Beutler B, Du X, Poltorak A: Identification of toll-like receptor 4 (tlr4) as the sole conduit for lps signal transduction: Genetic and evolutionary studies. J Endotoxin Res 2001;7:277-280.
39. Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA: Toll-like receptor 4 expression levels determine the degree of lps-susceptibility in mice. Eur J Immunol 2003;33:798-805.
40. Lavelle EC, Murphy C, O'Neill LA, Creagh EM: The role of tlrs, nlrs, and rlrs in mucosal innate immunity and homeostasis. Mucosal Immunol 2010;3:17-28.
41. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of myd88-deficient mice to endotoxin. Immunity 1999;11:115-122.
42. Takeuchi O, Hoshino K, Akira S: Cutting edge: Tlr2-deficient and myd88-deficient mice are highly susceptible to staphylococcus aureus infection. J Immunol 2000;165:5392-5396.
43. Ahmad R, El Bassam S, Cordeiro P, Menezes J: Requirement of tlr2-mediated signaling for the induction of il-15 gene expression in human monocytic cells by hsv-1. Blood 2008;112:2360-2368.
44. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S: Cellular responses to bacterial cell wall components are mediated through myd88-dependent signaling cascades. Int Immunol 2000;12:113-117.
45. Newton K, Dixit VM: Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 2012;4
46. Bauerfeld CP, Rastogi R, Pirockinaite G, Lee I, Huttemann M, Monks B, Birnbaum MJ, Franchi L, Nunez G, Samavati L: Tlr4-mediated akt activation is myd88/trif dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor a in murine macrophages. J Immunol 2012;188:2847-2857.
47. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the myd88 gene results in loss of il-1-and il-18-mediated function. Immunity 1998;9:143-150.
48. Gracie JA, Robertson SE, McInnes IB: Interleukin-18. J Leukoc Biol 2003;73:213-224.
49. Eaves-Pyles T, Szabo C, Salzman AL: Bacterial invasion is not required for activation of nf-kappab in enterocytes. Infect Immun 1999;67:800-804.
50. Hauf N, Goebel W, Fiedler F, Sokolovic Z, Kuhn M: Listeria monocytogenes infection of p388d1 macrophages results in a biphasic nf-kappab (rela/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by ikappabalpha and ikappabbeta degradation. Proc Natl Acad Sci U S A 1997;94:9394-9399.
51. Gupta D, Wang Q, Vinson C, Dziarski R: Bacterial peptidoglycan induces cd14-dependent activation of transcription factors creb/atf and ap-1. J Biol Chem 1999;274:14012-14020.
52. Rawadi G, Ramez V, Lemercier B, Roman-Roman S: Activation of mitogen-activated protein kinase pathways by mycoplasma fermentans membrane lipoproteins in murine macrophages: Involvement in cytokine synthesis. J Immunol 1998;160:1330-1339.
53. Wilhelmsen K, Mesa KR, Lucero J, Xu F, Hellman J: Erk5 protein promotes, whereas mek1 protein differentially regulates, the toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes. J Biol Chem 2012;287:26478-26494.
54. Baseman JB, Tully JG: Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997;3:21-32.
55. Taylor-Robinson D, Schaeverbeke T: Mycoplasmas in rheumatoid arthritis and other human arthritides. J Clin Pathol 1996;49:781-782.
56. Blanchard A, Montagnier L: Aids-associated mycoplasmas. Annu Rev Microbiol 1994;48:687-712.
57. Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahadevan LC: P38/rk is essential for stress-induced nuclear responses: Jnk/sapks and c-jun/atf-2 phosphorylation are insufficient. Curr Biol 1996;6:1028-1031.
58. Cano E, Hazzalin CA, Kardalinou E, Buckle RS, Mahadevan LC: Neither erk nor jnk/sapk map kinase subtypes are essential for histone h3/hmg-14 phosphorylation or c-fos and c-jun induction. J Cell Sci 1995;108:3599-3609.
59. Cano E, Doza YN, Ben-Levy R, Cohen P, Mahadevan LC: Identification of anisomycin-activated kinases p45 and p55 in murine cells as mapkap kinase-2. Oncogene 1996;12:805-812.
60. Gordon GM, Ledee DR, Feuer WJ, Fini ME: Cytokines and signaling pathways regulating matrix metalloproteinase-9 (mmp-9) expression in corneal epithelial cells. J Cell Physiol 2009;221:402-411.
61. Karin M: The regulation of ap-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
62. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G: Linking jnk signaling to nf-kappab: A key to survival. J Cell Sci 2004;117:5197-5208.